Evercore ISI lowered the firm’s price target on Ultragenyx (RARE) to $37 from $39 and keeps an Outperform rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RARE:
- Ultragenyx price target lowered to $50 from $60 at H.C. Wainwright
- Ultragenyx price target lowered to $45 from $50 at Citi
- Ultragenyx Earnings Call Balances Growth With Risk
- Ultragenyx Pharmaceutical Faces Lawsuit Following Clinical Trial Disclosures
- Ultragenyx price target lowered to $49 from $75 at TD Cowen